Brain protein shields neurons from Alzheimer’s damage in mice
A protein naturally present in the brain appears to curb much of the damage caused by Alzheimer’s disease. In mice, raising its levels reduced toxic protein clumps and brain shrinkage. Removing it made the damage worse.
The protein is called SORLA. Researchers at Sanford Burnham Prebys published their findings in the journal Science Advances. SORLA was already known for limiting the buildup of amyloid-beta, one of the two key proteins that cause damage in Alzheimer's disease. Its role in tau, the other such protein, had remained unclear.
Less tau, less brain shrinkage in mice
In Alzheimer’s disease, tau proteins clump together and damage neurons. To study this, the team bred mice that produced extra SORLA and crossed them with mice that develop tau tangles and brain atrophy. Mice with higher SORLA levels showed less tau accumulation, less brain shrinkage, and better-preserved connections between neurons (synapses).
One key mechanism involved hyperphosphorylation: tau proteins that bind too many phosphate groups become more harmful. SORLA reduced this process. It also limited the ability of misfolded tau to seed further clumping and spread damage to other cells.
Removing the protein worsened the damage
The team also studied mice that lacked the gene that makes SORLA. These mice showed the opposite pattern: tau damage was more severe. Some people carry variants in this gene, which may reduce their natural protection.
In detailed single-cell analyses, the researchers found that a signalling protein from the plexin-B family was unusually active when SORLA was absent. Drugs that target this family of proteins already exist, and the team suggests these might be investigated for use against tau-related dementias. This remains speculative and requires further study.
The protective effects were demonstrated in mice. Whether the same mechanisms operate in humans has not yet been established.
Search terms to explore further: tau-related brain disease, SORLA Alzheimer's disease, tau damage and synapse loss